The binding of XPB to BCR in BCR-ABL reduced the ATPase and helicase activity of XPB, suggesting that the dysfunction of XPB may play a part in blastic crisis in CML [68]. This evidence concerns the gene ERCC3 and chronic myelogenous leukemia, BCR-ABL1 positive.